Skip to main content
Acticor Biotech logo

Acticor Biotech — Investor Relations & Filings

Ticker · ALACT ISIN · FR0012519668 LEI · 969500K433EK1G89EV95 PA Manufacturing
Open in API
Filings indexed 200 across all filing types
Latest filing 2023-05-09 Declaration of Voting R…
Country FR France
Listing PA ALACT

About Acticor Biotech

https://www.acticor-biotech.com

Acticor Biotech is a clinical-stage biopharmaceutical company that originated as a spin-off from the French National Institute of Health and Medical Research (INSERM). The company is dedicated to developing innovative treatments for thrombotic diseases, with a primary focus on the acute phase of ischemic stroke. Its lead drug candidate, glenzocimab, is a humanized monoclonal antibody fragment designed to target platelet glycoprotein VI (GPVI), a key receptor involved in thrombosis. The therapeutic approach aims to provide an effective anti-thrombotic effect to safely manage stroke patients without increasing the risk of bleeding, a significant complication associated with existing treatments.

Recent filings

Filing Released Lang Actions
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Disclosure of the total number of voting rights and shares as of April 30, 2023" and explicitly references compliance with Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the French Financial Markets Authority (AMF). This type of mandatory disclosure, which reports the total number of shares and voting rights on a specific date, is a standard regulatory filing in France. Since it is a specific regulatory disclosure that doesn't fit the definitions for AGM-R, 10-K, ER, or IR, and it is a direct regulatory announcement rather than a general report announcement (RPA), the most appropriate classification is the general regulatory filing category, RNS, as it is a specific, required disclosure to the market.
2023-05-09 English
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rapport financier annuel
Report Publication Announcement Classification · 98% confidence The document is a press release dated April 26, 2023, announcing the 'Mise à disposition' (making available) of two key items: 1) The 2022 Universal Registration Document (Document d'enregistrement universel 2022), which includes the annual report and management report, filed with the AMF. 2) The preparatory documents for the upcoming Annual General Meeting (AGM) scheduled for May 12, 2023. Since the document's primary function is to announce that these reports and meeting materials are now available to the public and shareholders, and it is relatively short (6022 chars), it fits the definition of a Report Publication Announcement (RPA). While it mentions the AGM, the core action described is the publication/availability of documents, not the AGM results (DVA) or the AGM presentation itself (AGM-R). It is an announcement about the availability of the 10-K equivalent (Universal Registration Document) and AGM materials.
2023-04-26 French
Annual financial and audit reports / Terms of availability of the annual financial report
Report Publication Announcement Classification · 98% confidence The document is an announcement titled "Availability of the 2022 Universal Registration Document and the preparatory documents for the combined general meeting of May 12, 2023". It explicitly states that the 2022 Universal Registration Document (URD) is filed and available, and it also mentions the preparatory documents for the upcoming General Meeting. Since the text is an announcement *about* the availability of reports (URD, which contains the annual financial report, and AGM documents) rather than the full reports themselves, and it is announcing the availability of documents related to a future general meeting, it fits the description of a Report Publication Announcement (RPA). The URD filing itself might be equivalent to a 10-K in content, but this specific document is the *notice* of its availability. Furthermore, it mentions the AGM documents, which aligns with the context of meeting preparation announcements.
2023-04-26 English
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release titled "Disclosure of the total number of voting rights and shares as of March 31, 2023". It explicitly states the total number of shares and voting rights as required by French Commercial Code and AMF regulations. This type of mandatory disclosure regarding the capital structure and voting rights is a specific regulatory announcement. It is not a full annual report (10-K), an earnings release (ER), or a dividend notice (DIV). Since it is a specific regulatory disclosure concerning share capital and voting rights, it fits best under the general category of regulatory filings (RNS) or potentially a specific capital/financing update (CAP). However, given the precise nature of disclosing the total number of voting rights, which is a recurring regulatory requirement often filed separately from major financial reports, RNS (Regulatory Filings) is the most appropriate general classification for this type of mandatory, non-financial-result-focused announcement that doesn't fit other specific codes like DIRS or SHA (which usually relate to transactions). Given the options, RNS serves as the best fit for this specific regulatory disclosure not covered by other codes.
2023-04-11 English
Informations privilégiées / Autres communiqués
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social au 31 mars 2023" (Monthly information relating to the total number of voting rights and shares comprising the share capital as of March 31, 2023). It explicitly references Article 223-16 of the AMF General Regulation and provides a table detailing the total number of shares and voting rights as of a specific date (March 31, 2023). This type of regular disclosure concerning the total number of shares and voting rights is a specific regulatory requirement, often related to capital structure changes or mandatory periodic reporting. While it is a press release, its core content is a mandatory disclosure about share capital and voting rights. This content is most closely aligned with notifications regarding capital structure or significant shareholding changes, but since it is a mandatory monthly disclosure of the total share count, it fits best under the general category for regulatory announcements that aren't specifically about dividends, director dealings, or major shareholding changes crossing a threshold (MRQ). However, given the options, a mandatory disclosure about the total number of shares and voting rights is a fundamental piece of corporate structure information. It is not a 10-K, IR, ER, or CT. It is a specific regulatory update. Since there isn't a perfect fit for 'Total Share Count Disclosure', we must evaluate the closest options. It is not a Director's Dealing (DIRS), a Dividend Notice (DIV), or a Major Shareholding Notification (MRQ, which usually concerns changes crossing a threshold). It is a mandatory regulatory filing/communication. Given the options, RNS (Regulatory Filings) is the most appropriate fallback for mandatory, periodic regulatory disclosures that don't fit a more specific category like DIV or DIRS. Alternatively, it relates closely to capital structure, but CAP is for fundraising/financing activities, not just reporting the existing structure. Therefore, RNS is the best fit as a general regulatory disclosure.
2023-04-11 French
Document d'Enregistrement Universel 2022
Audit Report / Information Classification · 98% confidence The document is explicitly titled "DOCUMENT D'ENREGISTREMENT UNIVERSEL 2022 incluant le rapport annuel et le rapport de gestion" (Universal Registration Document 2022 including the annual report and management report). The Universal Registration Document (URD) in the EU regulatory framework often serves as the comprehensive annual filing, similar in scope to a US 10-K, containing the annual report and management report. It mentions approval by the AMF (Autorité des marchés financiers) and covers the full fiscal year 2022, which aligns with the purpose of an Annual Report (10-K). Although the French term is URD, given the provided definitions, the closest equivalent for a comprehensive annual filing containing the annual report is '10-K'. The document length is very large (1.4M characters), confirming it is the full report, not just an announcement (RPA). FY 2022
2023-03-31 French

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.